Medicale CORP

Market Movers (8-K)

OTC.Pink
Medicale Corp. has dismissed GreenGrowth CPAs and appointed Victor Mokuolu, CPA PLLC as its new independent registered public accounting firm, effective December 31, 2024.

Quarterly Earnings (10-Q)

OTC.Pink
Medicale Corp. reported a reduced net loss for Q1 2026, but faces significant going concern doubts and ineffective internal controls as it remains pre-operational.
Delay expected
Worse than expected
Capital raise
OTC.Pink
Medicale Corp. reports continued losses and zero revenue for Q3 2025, raising substantial doubt about its ability to continue as a going concern.
Capital raise
Worse than expected
OTC.Pink
Medicale Corp. reports a reduced net loss for the three and six months ended March 31, 2025, while continuing efforts to raise capital and commence operations.
Capital raise
Better than expected
OTC.Pink
Medicale Corp. files an amendment to its Q1 2025 10-Q report solely to correct typographical errors, with no material changes to the original filing.
Worse than expected
Capital raise
OTC.Pink
Medicale Corp. reports a decreased net loss for the quarter ended December 31, 2024, while continuing efforts to raise capital and commence operations.
Better than expected
Capital raise
OTC.Pink
Medicale Corp. reports a net loss of $41,332 for the nine months ended June 30, 2024, as it continues to seek additional funding.
Worse than expected
Capital raise

Annual Reports (10-K)

OTC.Pink
Medicale Corp. reports no operations, a widening working capital deficit, and a going concern warning in its 2025 annual filing.
Delay expected
Capital raise
Worse than expected
OTC.Pink
Medicale Corp.'s 2024 annual report reveals a net loss of $58,213 and ongoing concerns about the company's ability to continue as a going concern.
Capital raise
Worse than expected